New Developments in Atopic Dermatitis and Implications for the Atopic March

3305:

Allergic and Immunologic Skin Diseases

Sunday, March 4, 2018: 10:45 AM-12:00 PM

Convention Center, South Concourse, Level 3, S320CD

1.25 CME/CE

Symposium

Moderator:

Lynda C. Schneider, MD FAAAAI

Learning Objectives:

Discuss the basis of emerging anti-cytokine(anti-TH2, Th22 and Th 17) biologics in the treatment of AD
Discuss other potential therapeutic targets for AD, including JAK inhibitors, PDE4 antagonists, H4R antagonists in AD, and which inflammatory axes are targeted in clinical efficacy and safety data
Discuss new strategies for preventing AD in hgh risk children and their potential role in preventing other atopic manifestations such as food allergies

10:45 AM

Cytokines and Anticytokine Therapies in AD and Other Atopic Diseases
Emma Guttman-Yassky, MD PhD

Recipient of the Hugh A. Sampson Lectureship in Food Allergy: 3^rd year

11:00 AM

Question & Answer

11:05 AM

Other Biologics with Potential for Treating AD
Lisa A. Beck, MD FAAAAI

11:20 AM

Question & Answer

11:25 AM

Therapeutic Interventions to Prevent AD and the Atopic March
Donald Y. M. Leung, MD PhD FAAAAI

11:40 AM

Question & Answer

See more of: Session